Vivian Resende

Dr. Vivian Resende

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in The American Journal of Surgery
Verified
Journal Article
Closed access
VRVivian Resende
Vivian Resende
APAndy Petroianu
Andy Petroianu

1 March 2012 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MPM. Pai
M. Pai
AFA.E. Frampton
A.E. Frampton
SMS. Mikhail
S. Mikhail
VRVivian Resende
Vivian Resende
OKO. Kornasiewicz
O. Kornasiewicz
NHNagy Habib
Nagy Habib

1 May 1998 in The Journal of Trauma: Injury, Infection, and Critical Care
Verified
Journal Article
Closed access
VRVivian Resende
Vivian Resende
APAndy Petroianu
Andy Petroianu
The spleen is an organ of the defense system with important roles in filtering functions, phagocytosis, and immunoglobulin production. Septic phenomena are severe complications that may occur after total splenectomy. To avoid these adverse effects, the preservation of the spleen is indicated. However, in the presence of severe spleen damage, lesions of the splenic pedicle, or both, complete removal of the spleen has been considered unavoidable. The present paper presents the preservation of the upper splenic pole supplied by the splenogastric vessels in six patients with severe injuries of the spleen and its pedicle. All patients had good postoperative courses. Subtotal splenectomy may be useful in the treatment of severe injuries of the distal part of the spleen, when the vessels of its pedicle are damaged, or both.

1 July 2010 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
IVIzabela Voieta
Izabela Voieta
LQLeonardo C de Queiroz
Leonardo C de Queiroz
LALuciene M Andrade
Luciene M Andrade
LSLuciana Cristina S Silva
Luciana Cristina S Silva
VFVitor F Fontes
Vitor F Fontes
JLJosé Roberto Lambertucci
José Roberto Lambertucci
Few publications have compared ultrasound (US) to histology in diagnosing schistosomiasis-induced liver fibrosis (LF); none has used magnetic resonance (MR). The aim of this study was to evaluate schistosomal LF using these three methods. Fourteen patients with hepatosplenic schistosomiasis admitted to hospital for surgical treatment of variceal bleeding were investigated. They were submitted to upper digestive endoscopy, US, MR and wedge liver biopsy. The World Health Organization protocol for US in schistosomiasis was used. Hepatic fibrosis was classified as absent, slight, moderate or intense. Histology and MR confirmed Symmers' fibrosis in all cases. US failed to detect it in one patient. Moderate agreement was found comparing US to MR; poor agreement was found when US or MR were compared to histology. Re-classifying LF as only slight or intense created moderate agreement between imaging techniques and histology. Histomorphometry did not separate slight from intense LF. Two patients with advanced hepatosplenic schistosomiasis presented slight LF. Our data suggest that the presence of the characteristic periportal fibrosis, diagnosed by US, MR or histology, associated with a sign of portal hypertension, defines the severity of the disease. We conclude that imaging techniques are reliable to define the presence of LF but fail in grading its intensity.

1 September 2015 in Clinical Science
Verified
Journal Article
Open access
PDF file
Thiago PereiraThiago Pereira
Thiago Pereira
WSWing-Kin Syn
Wing-Kin Syn
MMMariana V. Machado
Mariana V. Machado
PVPaula V. Vidigal
Paula V. Vidigal
VRVivian Resende
Vivian Resende
ADAnna Mae Diehl
Anna Mae Diehl
Schistosomiasis is a major cause of portal hypertension worldwide. It associates with portal fibrosis that develops during chronic infection. The mechanisms by which the pathogen evokes these host responses remain unclear. We evaluated the hypothesis that schistosome eggs release factors that directly stimulate liver cells to produce osteopontin (OPN), a pro-fibrogenic protein that stimulates hepatic stellate cells to become myofibroblasts. We also investigated the utility of OPN as a biomarker of fibrosis and/or severity of portal hypertension. Cultured cholangiocytes, Kupffer cells and hepatic stellate cells were treated with soluble egg antigen (SEA); OPN production was quantified by quantitative reverse transcriptase polymerase chain reaction (qRTPCR) and ELISA; cell proliferation was assessed by BrdU (5-bromo-2'-deoxyuridine). Mice were infected with Schistosoma mansoni for 6 or 16 weeks to cause early or advanced fibrosis. Liver OPN was evaluated by qRTPCR and immunohistochemistry (IHC) and correlated with liver fibrosis and serum OPN. Livers from patients with schistosomiasis mansoni (early fibrosis n=15; advanced fibrosis n=72) or healthy adults (n=22) were immunostained for OPN and fibrosis markers. Results were correlated with plasma OPN levels and splenic vein pressures. SEA-induced cholangiocyte proliferation and OPN secretion (P<0.001 compared with controls). Cholangiocytes were OPN (+) in Schistosoma-infected mice and humans. Liver and serum OPN levels correlated with fibrosis stage (mice: r=0.861; human r=0.672, P=0.0001) and myofibroblast accumulation (mice: r=0.800; human: r=0.761, P=0.0001). Numbers of OPN (+) bile ductules strongly correlated with splenic vein pressure (r=0.778; P=0.001). S. mansoni egg antigens stimulate cholangiocyte proliferation and OPN secretion. OPN levels in liver and blood correlate with fibrosis stage and portal hypertension severity.

1 October 2002 in Emergency Radiology
Verified
Journal Article
Closed access
PDF file
VRVivian Resende
Vivian Resende
APAndy Petroianu
Andy Petroianu
WJWilson C. Junior
Wilson C. Junior